ORG27569 (1) is an allosteric modulator of CB1. 1 produces a distinct cAMP temporal fingerprint with complex time-dependent modulation of agonist-mediated responses. The aim of this study was to characterize the cAMP signaling response of indole-2-carboxamides structurally correlated to 1 for both CB1 and CB2. We show that at CB1 1, 10, 13, and 18 display a delay in inhibiting CP55,940-mediated cAMP inhibition, whereas compounds 7, 14, 15, 16, 20, and 22 act immediately. To further characterize this, compounds 1, 10, 13, 14, 15, 18, and 20 were tested for their influence on CP55,940-mediated hyperpolarization in AtT20-hCB1 cells. Intriguingly, all compounds generated a response similar to that of 1, producing no decrease in CB1-mediated pea...
Cannabinoid receptors couple to both Gs and Gi proteins and can consequently stimulate or inhibit th...
The CB1 cannabinoid receptor is a widely distributed G-protein coupled receptor in human central and...
Adenosine A1 and cannabinoid CB1 receptors are highly expressed in hippocampus where they trigger si...
Background and Purpose: The cannabinoid receptor type 1 (CB₁) has an allosteric binding site. The dr...
CB1 allosteric modulators provide new opportunities to specifically regulate biological responses me...
The cannabinoid CB1 receptor is involved in complex physiological functions. The discovery of CB1 al...
We synthesized new N-phenylethyl-1H-indole-2-carboxamides as the first SAR study of allosteric modul...
We synthesized new <i>N</i>-phenylethyl-1<i>H</i>-indole-2-carboxamides as the first SAR study of al...
A series of substituted 1-indole-2-carboxamides structurally related to compounds Org27569 (), Org29...
AbstractThe aminoalkylindole BML-190 and diarylpyrazole AM251 ligands have previously been shown to ...
We investigated the pharmacology of three novel compounds, Org 27569 (5-chloro-3-ethyl-1H-indole-2-c...
The mechanism of action of cannabidiol (CBD), the main non-psychotropic component of Cannabis sativa...
The mechanism of action of cannabidiol (CBD), the main non-psychotropic component of Cannabis sativa...
The cannabinoid receptor type 1 (CB1 ) has an allosteric binding site. The drugs ORG27569 {5-chloro-...
During this study the [35S]GTPγS binding, equilibrium binding and dissociation kinetic assays were u...
Cannabinoid receptors couple to both Gs and Gi proteins and can consequently stimulate or inhibit th...
The CB1 cannabinoid receptor is a widely distributed G-protein coupled receptor in human central and...
Adenosine A1 and cannabinoid CB1 receptors are highly expressed in hippocampus where they trigger si...
Background and Purpose: The cannabinoid receptor type 1 (CB₁) has an allosteric binding site. The dr...
CB1 allosteric modulators provide new opportunities to specifically regulate biological responses me...
The cannabinoid CB1 receptor is involved in complex physiological functions. The discovery of CB1 al...
We synthesized new N-phenylethyl-1H-indole-2-carboxamides as the first SAR study of allosteric modul...
We synthesized new <i>N</i>-phenylethyl-1<i>H</i>-indole-2-carboxamides as the first SAR study of al...
A series of substituted 1-indole-2-carboxamides structurally related to compounds Org27569 (), Org29...
AbstractThe aminoalkylindole BML-190 and diarylpyrazole AM251 ligands have previously been shown to ...
We investigated the pharmacology of three novel compounds, Org 27569 (5-chloro-3-ethyl-1H-indole-2-c...
The mechanism of action of cannabidiol (CBD), the main non-psychotropic component of Cannabis sativa...
The mechanism of action of cannabidiol (CBD), the main non-psychotropic component of Cannabis sativa...
The cannabinoid receptor type 1 (CB1 ) has an allosteric binding site. The drugs ORG27569 {5-chloro-...
During this study the [35S]GTPγS binding, equilibrium binding and dissociation kinetic assays were u...
Cannabinoid receptors couple to both Gs and Gi proteins and can consequently stimulate or inhibit th...
The CB1 cannabinoid receptor is a widely distributed G-protein coupled receptor in human central and...
Adenosine A1 and cannabinoid CB1 receptors are highly expressed in hippocampus where they trigger si...